“Patient- and Clinician-Reported Outcomes of Tirbanibulin 1% in the Treatment of Actinic Keratosis on the Face and Scalp (PROAK Study)” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s262. doi:10.25251/skin.7.supp.262.